CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 10, 2009--
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by Lazard Capital Markets on Tuesday,
November 17, 2009, at 3:10 p.m. ET from the St. Regis Hotel in New York.
The presentation may be accessed under the investor relations tab at www.alkermes.com.
The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL® for
alcohol dependence and manufactures RISPERDAL® CONSTA®
for schizophrenia and bipolar I disorder. Alkermes' robust pipeline
includes extended-release injectable, pulmonary and oral products for
the treatment of prevalent, chronic diseases, such as central nervous
system disorders, addiction and diabetes. Headquartered in Cambridge,
Massachusetts, Alkermes has research facilities in Massachusetts and a
commercial manufacturing facility in Ohio.
Eva Stroynowski, 617-583-6823